Iqvia Holdings (IQV) Interest & Investment Income (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Interest & Investment Income came in at $7.0 million in Q2 2026, down 30.0% year-over-year from $10.0 million in Q2 2025, and down 30.0% quarter-over-quarter from $10.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Interest & Investment Income (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Interest & Investment Income across 15 years of filings, most recently posting $7.0 million for Q2 2026.
- In Q2 2026, Interest & Investment Income fell 30.0% year-over-year to $7.0 million; the TTM figure through Jun 2026 stood at $41.0 million (down 8.89% YoY), while the FY2025 annual figure was $45.0 million, down 4.26% from the prior year.
- Interest & Investment Income came in at $7.0 million for Q2 2026 at Iqvia Holdings, down from $10.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $14.0 million in Q3 2023 to a low of $1.0 million in Q1 2022.
- Average Interest & Investment Income over 5 years is $8.8 million, with a median of $10.5 million recorded in 2024.
- Year-over-year, Interest & Investment Income jumped 500.0% in 2023 and sank 30.0% in 2026.
- Over 5 years, Interest & Investment Income stood at $6.0 million in 2022, then soared by 100.0% to $12.0 million in 2023, then dropped by 8.33% to $11.0 million in 2024, then changed by 0.0% to $11.0 million in 2025, then tumbled by 36.36% to $7.0 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $7.0 million in Q2 2026, $10.0 million in Q1 2026, and $11.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.99 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.16 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.03 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -19.30 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -210,000.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 12,909.62 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 28,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.00 Mn |
| Mar 31, 2026 | 10.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 11.00 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Mar 31, 2023 | 6.00 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 2.00 Mn |